Clinical trials
Phase 3 trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4,760 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 14 |
| 2001 | 37 |
| 2002 | 40 |
| 2003 | 69 |
| 2004 | 92 |
| 2005 | 114 |
| 2006 | 150 |
| 2007 | 160 |
| 2008 | 181 |
| 2009 | 172 |
| 2010 | 191 |
| 2011 | 208 |
| 2012 | 186 |
| 2013 | 199 |
| 2014 | 209 |
| 2015 | 217 |
| 2016 | 180 |
| 2017 | 245 |
| 2018 | 238 |
| 2019 | 222 |
| 2020 | 216 |
| 2021 | 281 |
| 2022 | 236 |
| 2023 | 234 |
| 2024 | 237 |
| 2025 | 252 |
| 2026 | 139 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2,965 |
| Active, not recruiting | 638 |
| Terminated | 535 |
| Recruiting | 492 |
| Unknown status | 74 |
| Enrolling by invitation | 26 |
| Withdrawn | 15 |
| Not yet recruiting | 9 |
| Suspended | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 282 |
| Hoffmann-La Roche | 250 |
| Novartis Pharmaceuticals | 205 |
| Pfizer | 183 |
| Eli Lilly and Company | 167 |
| Sanofi | 158 |
| GlaxoSmithKline | 149 |
| Janssen Research & Development, LLC | 149 |
| Bristol-Myers Squibb | 129 |
| Amgen | 114 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 212 |
| Carcinoma, Non-Small-Cell Lung | 184 |
| Breast Neoplasms | 145 |
| Asthma | 110 |
| Arthritis, Rheumatoid | 102 |
| Diabetes Mellitus | 93 |
| Neoplasms | 93 |
| Neoplasm Metastasis | 86 |
| Colitis, Ulcerative | 81 |
| Pulmonary Disease, Chronic Obstructive | 81 |
Trials
Showing 1 to 25 of 4,760. Each trial links to its page on Pharma Observatory.
4,660 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.